Skip to main content
Log in

Sulindac usage may not be associated with an increased incidence of renal stone formation in patients with rheumatoid arthritis

  • Letter
  • Published:
Japanese Journal of Rheumatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Rare complication with sulindac,FDA Drug Bull 19, 4 (1989).

    Google Scholar 

  2. Paulus HE, FDA arthritis advisory committee meeting: serious gastrointestinal toxicity of nonsteroidal antiinflammatory drugs; drug-containing renal and biliary stones; diclofenac and carprofen approved,Arthritis Rheum 31, 1450–1451 (1988).

    Article  Google Scholar 

  3. Ito S, Nozawa S, Ishikawa Het al., Renal stones in rheumatoid arthritis patients,J Rheumatol 24, 2123–2128 (1997).

    PubMed  CAS  Google Scholar 

  4. Aratani M, Tanabashi S, Takakuwa Eet al., A general status of the health consultation center of this hospital during these 3 years (1987 to 1989),Takayama Red Cross Hospital Kiyou 14, 14–46 (1990).

    Google Scholar 

  5. Steinbrocker O, Traeger CH, Batterman RC, Therapeutic criteria in rheumatoid arthritis,J Am Med Ass 140, 659–662 (1949).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Ito, S., Hasegawa, H., Nozawa, S. et al. Sulindac usage may not be associated with an increased incidence of renal stone formation in patients with rheumatoid arthritis. Japanese Journal of Rheumatology 9, 119–121 (1999). https://doi.org/10.1007/BF03041268

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03041268

Keywords

Navigation